Please assess the completion status of the following clinical trial:

Trial Title: Comparison of Phase-variance Optical Coherence Tomography and Fluorescein Angiography in Retinovascular Imaging

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~1. Patients with suspected or established retinovascular disease who are going to undergo FA as part of their usual clinical evaluation.~2. Patients must be age 13 or above.~3. Patients must be able to speak and understand the English language in order to provide informed consent.~Exclusion Criteria:~1. Any patients who are unwilling to participate or provide informed consent.~2. Any patients who are pregnant at the time of enrollment.~3. Any patients with ocular media opacities which prevent clear evaluation of the fundus by either FA or OCT.

- Gender: ALL
- Minimum Age: 13 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- PVOCT (Type: None): Subjects will receive fluorescein angiography (FA) as part of their normal clinical evaluation and will undergo phase variance optical coherence tomography (PV-OCT) as the study intervention. This involves having subjects undergo standard, noninvasive optical coherence tomography (OCT) scans with an FDA-approved OCT device, and the data gathered by this device will be transferred to a separate computer for processing using novel software. This software is capable of utilizing the existing data to generate phase variance OCT images.

Based on this trial design, predict the completion outcome and termination type (if applicable).